Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5329-5332

  Goggins, Michael ^a   Shekher, Manu ^a   Turnacioglu, Kenan ^a   Yeo, Charles J ^a   Hruban, Ralph H ^a   Kern, Scott E ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CELL DIFFERENTIATION; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE INACTIVATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS; ADENOCARCINOMA; AGED; BILIARY TRACT NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA-BINDING PROTEINS; FEMALE; GENES, P16; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032404111     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Heldin, C. H., Miyazono, K., and ten Dijke, P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature (Lond.), 390: 465-471, 1997.
2. Hahn, S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., deCosta, L. T., Rozenblum, E., Weinsten, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 277: 350-353, 1996.
3. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kanzler, K. W., Vogelstein, B., Brattain, M., and Wilson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatcllite instability. Science (Washington DC), 268: 1336-1338, 1995.
4. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
5. Riggins, G. J., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. R. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Mad-related genes in the human. Nat. Genet., 13: 347-349, 1996.
6. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
7. Park, K., Kim, S. J., Bang, Y. J., Park, J. G., Kim, N. K., Roberts, A. B., and Sporn, M. B. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994.
8. Pasche, B., Luo, Y., Rao, P. H., Nimer, S. D., Dmitrovsky, E., Caron, P., Luzzatto, L., Offit, K., Cordon-Cardo, C., Renault, B., Satagopan, J. M., Murty, V. V. V. S., and Massagué, J. Type I transforming growth factor β receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res., 58: 2727-2732, 1998.
9. Kim, I. Y., Ahn, H-J., Zelner, D. J., Shaw, J. W, Sensibar, J. A., Kim, J-H., Kato, M., and Lee, C. Genetic change in transforming growth factor β (TGF-B) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res., 56: 44-48, 1996.
10. Baldwin, R. L., Friess, H., Yokoyama, M., Lopez, M. E., Kobrin, M. S., Buchler, M. W., and Korc, M. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int. J. Cancer, 67: 283-288, 1996.
11. Kimchi, A., Wang, X. F., Weinberg, R. A., Cheifetz, S., and Massagué, J. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science (Washington DC), 240: 196-199, 1988.
12. Wang, J., Han, W., Zborowska, E., Liang, J., Wang, X., Willson, J. K. V., and Brattain, M. G. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem., 271: 17366-17371, 1996.
13. DeCoteau, J. F., Knaus, P. I., Yankelev, H., Reis, M. D., Lowsky, R., Lodish, H. F., and Kadin, M. E. Loss of functional cell surface transforming growth factor β (TGF-β) type I receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 94: 5877-5881, 1997.
14. Schutte, M., Hruban, R. H., Hedrick, L. Cho, K. R., Nadasdy G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Meltzer, P. S., Hahn, S.A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.
15. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-32, 1994.
16. Goggins, M., Schutte, M., Lu, J., Moskaluk, C. A., Weinstein, C. L., Petersen, G. M., Yeo, C. J., Jackson, C. E., Lynch, H. T., Hruban, R. H., and Kern, S. E. Germ-line BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res., 56: 5360-5364, 1996.
17. Caldas, C., Hahn, S. A., Hruban, R. H., Redston, M. S., Yeo, C. J., and Kern, S. E. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res., 54: 3568-3573, 1994.
18. Souchelnytskyi, S., ten Dijke, P., Miyazono, K., and Heldin, C. H. Phosphorylation of Ser165 in TGF-β type 1 receptor modulates TGF-β1-induced cellular responses. EMBO J., 15: 6231-6240, 1996.
19. Goggins, M., Offerhaus, G. J. A., Hilgers, W., Griffin, C. A., Shekher, M., Tang, D., Sohn, T., Yeo, C. J., Kern, S. E., and Hruban, R. H. Adenocarcinomas of the pancreas with DNA replication errors (RER+) are associated with a characteristic histopathology: poor differentiation, a syncytial growth pattern, and pushing borders suggest RER. Am. J. Pathol., 152: 1501-1507, 1998.
20. Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S. J, Stenzel T. T., Speer, M., Pericak-vance, M. A., Diamond, A., Guitmacher, A. E., Jackson, C. E., Attisano, L., Kucherlapati, R., Porteous, M. E., and Marchuk, D. A. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet., 13: 189-195, 1996.
21. Rozenblum, E., Schutte, M., and Kern, S. E. INK4 genes in pancreatic carcinoma. Oncol. Rep., 3: 743-745, 1996.
22. Reiss M. Transforming growth factor-β and cancer: a love-hate relationship? Oncol. Res., 9: 447-457, 1997.
23. Rozenblum, E., Schutte, M., Goggins, M., Hahn, S. A., Lu, J., Panzer, S., Zahurak, M., Goodman, S. N., Hruban, R. H., Yeo, C. J., and Kern, S. E. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 57: 1731-1734, 1997.
24. Dai, J. L., Tumacioglu, K. K., Schutte, M., Sugar, A. Y., and Kern, S. E. DPC4 transcriptional activation and dysfunction in cancer cells. Cancer Res., 58: 4592-4597, 1998.
25. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., and Heldin, C. H. Characterization of type I receptors for transforming growth factor-β and activin. Science (Washington DC), 264: 101-104, 1994.
26. ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Estevez, M., Riddle, D. L., Ichijo, H., Heldin, C. H., and Miyazono, K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem., 269: 16985-16988, 1994.
27. Hannon, G. J., and Beach, D. p15INK4B is a potential effector of TGF-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
28. Stone, S., Dayananth, P., Jiang, P., Weaver-Feldhaus, J. M., Tavtigian, S. V. Cannon-Albright, L., and Kamb, A. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene, 11: 987-991, 1995.
29. Riggins, G. J., Kinzler, K. W., Vogelstein, B., and Thiagalingam, S. Frequency of SMAD gene mutations in human cancer. Cancer Res., 57: 2578-2581, 1997.